Athanase Innovation AB's receivables is $24M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Athanase Innovation AB (ATIN.ST) currently reports a receivables of $24M as of September 2026. That compares with $8.8M in the prior-year period — up 172.1% year over year. Use the charts on this page to explore Athanase Innovation AB's receivables history and peer comparisons.
Athanase Innovation AB's receivables increased from $8.8M to $24M — a 172.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Athanase Innovation AB reported $24M in receivables as of September 2026. That compares with $8.8M in the prior-year period — up 172.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Athanase Innovation AB, and consider following ATIN.ST for alerts when major investors trade the stock.